Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2022 Filed May 26, 2022 18:04 UTC Amendment |
ANDERSON JOSEPH B JRDirector
|
GrantCommon Stock | 4,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004418 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 F1 · shares: This Form 4 amendment is to correct an administrative error in column 4 and 5 of the Form 4 filed on May 23, 2022, which resulted in the number of restricted stock award reported as acquired by the reporting person being understated in the original filing. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 12:24 UTC |
Chiodo MatthewVice President of Sales
|
SaleCommon Stock | 5,700 | $29.24 | $166,667.43 |
DisclosureSEC source: 0001562180-22-003047 · primarydocument.xml · nonDerivative · entry 1 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,577 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.05 to $29.45. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 12:18 UTC |
Boehm NeilChief Technology Officer
|
SaleCommon Stock | 4,500 | $29.24 | $131,579.55 |
DisclosureSEC source: 0001562180-22-003046 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,022 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.05 to $29.45. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 74 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:03 UTC |
Downing Steven RPresident and CEO
|
SaleCommon Stock | 37,691 | $30.36 | $1,144,389.22 |
DisclosureSEC source: 0001562180-22-001719 · primarydocument.xml · nonDerivative · entry 3 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,641 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:03 UTC |
Downing Steven RPresident and CEO
|
GrantCommon Stock | 37,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001719 · primarydocument.xml · nonDerivative · entry 2 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,332 F3 · kind: 37,691 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:03 UTC |
Downing Steven RPresident and CEO
|
SaleCommon Stock | 21,246 | $30.36 | $645,079.55 |
DisclosureSEC source: 0001562180-22-001719 · primarydocument.xml · nonDerivative · entry 1 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,641 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:02 UTC |
Chiodo MatthewVice President of Sales
|
SaleCommon Stock | 9,549 | $30.36 | $289,930.56 |
DisclosureSEC source: 0001562180-22-001718 · primarydocument.xml · nonDerivative · entry 3 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,412 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:02 UTC |
Chiodo MatthewVice President of Sales
|
GrantCommon Stock | 9,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001718 · primarydocument.xml · nonDerivative · entry 2 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,961 F3 · kind: 9,549 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:02 UTC |
Chiodo MatthewVice President of Sales
|
SaleCommon Stock | 5,382 | $30.36 | $163,410.44 |
DisclosureSEC source: 0001562180-22-001718 · primarydocument.xml · nonDerivative · entry 1 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,412 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC |
Nash Kevin CChief Financial Officer
|
SaleCommon Stock | 10,052 | $30.36 | $305,202.84 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,732 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC |
Nash Kevin CChief Financial Officer
|
GrantCommon Stock | 10,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,784 F3 · kind: 10,052 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC |
Nash Kevin CChief Financial Officer
|
SaleCommon Stock | 5,666 | $30.36 | $172,033.36 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,732 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC |
Boehm NeilChief Technology Officer
|
SaleCommon Stock | 10,228 | $30.36 | $310,546.63 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,448 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC |
Boehm NeilChief Technology Officer
|
GrantCommon Stock | 10,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,676 F3 · kind: 10,228 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC |
Boehm NeilChief Technology Officer
|
SaleCommon Stock | 5,765 | $30.36 | $175,039.24 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,448 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC |
Ryan Scott PGeneral Counsel
|
SaleCommon Stock | 8,797 | $30.36 | $267,098.03 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC |
Ryan Scott PGeneral Counsel
|
GrantCommon Stock | 8,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,222 F3 · kind: 8,797 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:58 UTC |
Ryan Scott PGeneral Counsel
|
SaleCommon Stock | 4,958 | $30.36 | $150,536.78 |
DisclosureSEC source: 0001562180-22-001715 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:21 UTC |
Downing Steven RPresident and CEO
|
GrantCommon Stock | 27,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001659 · primarydocument.xml · nonDerivative · entry 1 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,887 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:17 UTC |
Nash Kevin CChief Financial Officer
|
GrantCommon Stock | 8,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001657 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,398 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:19 UTC |
Chiodo MatthewVice President of Sales
|
GrantCommon Stock | 6,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001658 · primarydocument.xml · nonDerivative · entry 1 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,794 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:16 UTC |
Ryan Scott PGeneral Counsel
|
GrantCommon Stock | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001656 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,383 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:14 UTC |
Boehm NeilChief Technology Officer
|
GrantCommon Stock | 7,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001655 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,213 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 15:21 UTC |
Downing Steven RPresident and CEO
|
SaleCommon Stock | 7,560 | $31.32 | $236,788.27 |
DisclosureSEC source: 0001562180-22-001533 · primarydocument.xml · nonDerivative · entry 2 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,024 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.16 to $31.48. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 673 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 15:12 UTC |
Nash Kevin CChief Financial Officer
|
SaleCommon Stock | 3,630 | $31.32 | $113,695.96 |
DisclosureSEC source: 0001562180-22-001532 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,012 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.16 to $31.48. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 329 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 17:38 UTC |
Ryan Scott PGeneral Counsel
|
SaleCommon Stock | 1,820 | $31.32 | $57,004.58 |
DisclosureSEC source: 0001562180-22-001534 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,836 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.16 to $31.48. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 91 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:41 UTC |
Boehm NeilChief Technology Officer
|
SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001535 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,187 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 162 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:44 UTC |
Chiodo MatthewVice President of Sales
|
SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001536 · primarydocument.xml · nonDerivative · entry 1 Chiodo Matthew · CIK 0001731933 · Vice President of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,656 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 267 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 15:21 UTC |
Downing Steven RPresident and CEO
|
SaleCommon Stock | 31,000 | $31.50 | $976,444.20 |
DisclosureSEC source: 0001562180-22-001533 · primarydocument.xml · nonDerivative · entry 1 Downing Steven R · CIK 0001577379 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,584 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 673 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 15:12 UTC |
Nash Kevin CChief Financial Officer
|
SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001532 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,642 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 329 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:38 UTC |
Ryan Scott PGeneral Counsel
|
SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001534 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,656 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 91 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC |
Wallace James HDirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC |
Wallace James HDirector
|
SaleCommon Stock | 7,000 | $36.23 | $253,642.90 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 F1 · price: This transaction was executed in multiple trades at prices ranging from $36.15 to $36.30. The price reported above reflects the weighted average price. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 20:42 UTC |
Wallace James HDirector
|
Exercise / conversionCommon Stock | 7,000 | $15.74 | $110,180.00 |
DisclosureSEC source: 0001562180-21-006799 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 14:36 UTC |
GOODE GARY FDirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 6,200 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006741 · primarydocument.xml · derivative · entry 3 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,200 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 14:36 UTC |
GOODE GARY FDirector
|
SaleCommon Stock | 6,200 | $35.68 | $221,211.04 |
DisclosureSEC source: 0001562180-21-006741 · primarydocument.xml · nonDerivative · entry 2 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,309 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.62 to $35.78. The price reported above reflects the weighted average price. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 14:36 UTC |
GOODE GARY FDirector
|
Exercise / conversionCommon Stock | 6,200 | $15.74 | $97,588.00 |
DisclosureSEC source: 0001562180-21-006741 · primarydocument.xml · nonDerivative · entry 1 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC |
Wallace James HDirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $17.46 | $0.00 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · derivative · entry 3 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC |
Wallace James HDirector
|
SaleCommon Stock | 7,000 | $35.19 | $246,297.80 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · nonDerivative · entry 2 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.09 to $35.23. The price reported above reflects the weighted average price. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 19:56 UTC |
Wallace James HDirector
|
Exercise / conversionCommon Stock | 7,000 | $17.46 | $122,220.00 |
DisclosureSEC source: 0001562180-21-006693 · primarydocument.xml · nonDerivative · entry 1 Wallace James H · CIK 0001398852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 16:41 UTC |
Schaum Richard ODirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 12,000 | $0.00 Strike: $11.20 | $0.00 |
DisclosureSEC source: 0001562180-21-006674 · primarydocument.xml · derivative · entry 2 Schaum Richard O · CIK 0001333446 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 16:41 UTC |
Schaum Richard ODirector
|
Exercise / conversionCommon Stock | 12,000 | $11.20 | $134,340.00 |
DisclosureSEC source: 0001562180-21-006674 · primarydocument.xml · nonDerivative · entry 1 Schaum Richard O · CIK 0001333446 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 17:58 UTC |
GOODE GARY FDirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 800 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006677 · primarydocument.xml · derivative · entry 5 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,200 Underlying: Common Stock · 800 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 17:58 UTC |
GOODE GARY FDirector
|
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 7,000 | $0.00 Strike: $17.46 | $0.00 |
DisclosureSEC source: 0001562180-21-006677 · primarydocument.xml · derivative · entry 4 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 17:58 UTC |
GOODE GARY FDirector
|
SaleCommon Stock | 7,800 | $35.71 | $278,572.32 |
DisclosureSEC source: 0001562180-21-006677 · primarydocument.xml · nonDerivative · entry 3 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,309 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.63 to $35.83. The price reported above reflects the weighted average price. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 17:58 UTC |
GOODE GARY FDirector
|
Exercise / conversionCommon Stock | 800 | $15.74 | $12,592.00 |
DisclosureSEC source: 0001562180-21-006677 · primarydocument.xml · nonDerivative · entry 2 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 17:58 UTC |
GOODE GARY FDirector
|
Exercise / conversionCommon Stock | 7,000 | $17.46 | $122,220.00 |
DisclosureSEC source: 0001562180-21-006677 · primarydocument.xml · nonDerivative · entry 1 GOODE GARY F · CIK 0001223646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC |
Ryan Scott PGeneral Counsel
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,580 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · derivative · entry 3 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC |
Ryan Scott PGeneral Counsel
|
SaleCommon Stock | 9,224 | $34.27 | $316,106.48 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · nonDerivative · entry 2 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,565 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| October 25, 2021 Filed Oct 25, 2021 20:36 UTC |
Ryan Scott PGeneral Counsel
|
Exercise / conversionCommon Stock | 4,580 | $16.01 | $73,325.80 |
DisclosureSEC source: 0001562180-21-006634 · primarydocument.xml · nonDerivative · entry 1 Ryan Scott P · CIK 0001651517 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.